A Cohort Dose-Escalation Phase 1 Study of Intravenous Infusion of Uricase-PEG 20.
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2010
At a glance
- Drugs Pegadricase (Primary)
- Indications Gout; Hyperuricaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 30 Apr 2010 Top-line results have been presented in an EnzymeRx media release.
- 23 Feb 2010 Status changed from recruiting to completed according to EnzymeRx media release.
- 09 Dec 2009 Planned number of patients (20) and official title added as reported by ClinicalTrials.gov.